Subscribe To
Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
BOSTON, May 09, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, provided a business and financial update for the first quarter 2023. Recent Business Highlights CUE-101 abstract accepted for presentation at […] The post Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Hig...
Read More
Posted: May 9 2023, 20:35
Author Name: forextv
Views: 081771